AstraZeneca slammed by advocacy group over drug discount denials

AstraZeneca decided it will begin denying the discount rates it offers under the federal 340B drug pricing program to on-site hospital pharmacies on Oct. 1, according to a statement from the British drugmaker.

” The action of AstraZeneca is a direct attack on the 340B drug rates program that will harm healthcare facilities, university hospital, and clinics as well as the rural and low-income Americans who rely on them for care,” the statement, attributed to 340B Health President and CEO Maureen Testoni, reads. “We think that refusing to provide discounts that the 340B statute requires is an infraction of federal law. We are getting in touch with Health and Human Services Secretary Azar to exercise his authority to stop these overcharges prior to they cause irreversible damage to the healthcare safeguard.”.

The following day, drug pricing company 340B Health issued a statement on AstraZenecas choice to deny 340B discounts to on-site hospital pharmacies.

The Aug. 17 declaration did not disclose the factor for the approaching discount denials, however detailed that all 340B prices for on-site hospital drug stores will be honored through Sept. 30.

Katie Adams –
Tuesday, August 18th, 2020
Print|Email.

340B Healths declaration likewise implicated AstraZeneca of being “among several major manufacturers” to just recently reject access to its drug pricing.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.

More articles on drug store: CVS partnering with Delta Air Lines for fast COVID-19 testing programSanofi inks $3.68 B deal to buy California autoimmune drugmakerUS to check benefits of remdesivir with second drug.

” The action of AstraZeneca is a direct attack on the 340B drug pricing program that will injure medical facilities, health centers, and clinics as well as the rural and low-income Americans who rely on them for care,” the declaration, associated to 340B Health President and CEO Maureen Testoni, reads. “We think that refusing to use discounts that the 340B statute requires is a violation of federal law. We are calling on Health and Human Services Secretary Azar to exercise his authority to stop these overcharges prior to they trigger long-term damage to the health care safety internet.”.

” If the administration will not utilize its authority to implement the law, we will pursue all legal and legal opportunities available to us to protect the safeguard,” the last sentence of 340B Healths declaration reads.